Search results
While working in the pathology department of the University of Münster, Domagk was invited to join the IG Farben branch at Elberfeld (later Wuppertal) in 1927. His duty was to test chemical compounds prepared at the IG Farben laboratory for potential drugs.
The problem of chemotherapy of bacterial infections could be solved neither by the experimental medical research worker nor by the chemist alone, but only by the two together working in very close cooperation over many years.
The supreme aim of chemotherapy is, in Domagk’s opinion, the cure and control of carcinoma and he was convinced that this will be, in the future, achieved. Domagk held honorary doctorates of the Universities of Bologna, Münster, Cordoba, Lima, Buenos Aires, and Giessen.
Apr 20, 2024 · Gerhard Domagk was a German bacteriologist and pathologist who was awarded the 1939 Nobel Prize for Physiology or Medicine for his discovery (announced in 1932) of the antibacterial effects of Prontosil, the first of the sulfonamide drugs.
- The Editors of Encyclopaedia Britannica
A few decades later, German scientists Josef Klarer, Fritz Mietzsch, and Gerhard Domagk discovered the antibacterial activity of a synthetic dye, prontosil, that could treat streptococcal and staphylococcal infections in mice. Domagk’s own daughter was one of the first human recipients of the drug, which completely cured her of a severe ...
Examines the life and contributions of Gerhard Domagk , who discovered the curative effects of two important drugs and winner of the 1939 Nobel Prize for medicine.
People also ask
How did Domagk contribute to chemo?
Who was Gerhard Domagk?
How did Domagk contribute to medicine?
Why did Gerhard Domagk win a Nobel Prize?
Introduced in 1935 by Gerhard Domagk (1895–1964), sulfa drugs, or sulfonamides, all of which are related to the compound sulfanilamide, provided the first successful therapies for many bacterial diseases.
